NCT05432011 (PENG-FLAT) is a NA clinical trial of PENG Block in Pain, sponsored by Campus Bio-Medico University.

Who is sponsoring NCT05432011?

NCT05432011 is sponsored by Campus Bio-Medico University.

What drugs are being tested in NCT05432011?

Interventions in NCT05432011: PENG Block, Lateral Femoral Cutaneous Nerve Block, Wound Infiltration.

What condition does NCT05432011 study?

NCT05432011 studies Pain, Postoperative Pain, Acute Pain, Analgesia, Hip Arthropathy, Postoperative Complications.

Is NCT05432011 still recruiting?

NCT05432011 is currently completed. Last updated 30 August 2023.

Last reviewed 2023-08-30 · How we verify

NCT05432011: PENG-FLAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PENG Block Plus Lateral Femoral Cutaneous Nerve Block for Posterolateral-approached Total Hip Arthroplasty

Completed NA Last updated 30 August 2023

What this trial tests

NA trial testing PENG Block in Pain in 50 participants. Completed in 25 May 2023.

Timeline

1 July 2022

Primary endpoint
18 May 2023

25 May 2023

Quick facts

Lead sponsor	Campus Bio-Medico University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 July 2022
Primary completion	18 May 2023
Estimated completion	25 May 2023
Sites	1 location across Italy

Drugs / interventions tested

PENG Block — full drug profile →
Lateral Femoral Cutaneous Nerve Block — full drug profile →
Wound Infiltration — full drug profile →

Conditions studied

Pain — all drugs for Pain →
Postoperative Pain — all drugs for Postoperative Pain →
Acute Pain — all drugs for Acute Pain →
Analgesia — all drugs for Analgesia →

Sponsor

Campus Bio-Medico University

Who can join

18 and older, any sex, with Pain or Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to analyze the effect of Pericapsular Nerve Group (PENG) Block combined with lateral femoral cutaneous nerve block vs. PENG block combined with wound infiltration for analgesia after elective hip replacement performed with a posters-lateral approach. Half of participants will receive a PENG Block combined with femoral lateral cutaneous nerve block, while the other half will receive PENG Block combined with wound infiltration

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Lateral Femoral Cutaneous Nerve Block or Wound Infiltration Combined with Pericapsular Nerve Group (PENG) Block for Postoperative Analgesia following Total Hip Arthroplasty through Posterior Approach: A Randomized Controlled Trial.
Pascarella G, Costa F, Strumia A, Ruggiero A, et al · · 2024 · cited 7× · PMID 38731203 · DOI 10.3390/jcm13092674

Verify or expand the search:

Other trials of PENG Block

Trials testing the same drug.

NCT07502248 — PENG Block With or Without PPD Block for Postoperative Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
NCT07263932 — PENG vs PHPB for Hip Arthroplasty Analgesia · recruiting
NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting
NCT06878963 — COmparison of PENG Block and SIFICB in Hip Fracture Surgeries · NA · not yet recruiting
NCT06842342 — The Analgesic Effect of Ultrasound-guided Sacral Erector Spinae, Pericapsular Nerve Block and Lumber Plexus Block for Pa · NA · completed

Other recruiting trials for Pain

Currently open trials in the same condition.

NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting

Other Campus Bio-Medico University trials

Trials by the same sponsor.

NCT07448350 — TENS for Restoring Somatotopic Sensory Feedback in Lower Limb Amputees and Improving Phantom Limb Perception · NA · not yet recruiting
NCT06860841 — Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM · Phase 4 · active not recruiting
NCT06834269 — Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis. · NA · recruiting
NCT06098040 — Long-Term Feedback Effect of FGM in Newly-Diagnosed T2D Patients · NA · active not recruiting
NCT05842148 — Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY) · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05432011 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Campus Bio-Medico University
Last refreshed: 30 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05432011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing